Vinorelbine and XR9576 to Treat Cancer

NCT00001944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer
Cancer
Lung Cancer
Ovarian Cancer

Interventions

DRUG: Vinorelbine
DRUG: XR9576

Sponsor

National Cancer Institute (NCI)